(PRESS RELEASE) TROLLHÄTTAN, Sweden, 30-Jan-2019 — /EuropaWire/ — NEVS (National Electric Vehicle Sweden) has just announced it purchased 20 percent minority stake in Koenigsegg’s parent company for EUR 150 million. The high-performance sports cars maker Koenigsegg will use the new capital to accelerate … Read the full press release
Posted in Automotive, Financial, Investment, News, Sweden, Technology
Tagged advanced cars, automotive, Autonomous Vehicles, Christian von Koenigsegg, electric vehicles, electrification, EV, EV cars, Evergrande, fully electric premium vehicles, high-performance sports cars, hyper car, intellectual property, investment, Kai Johan Jiang, Koenigsegg, mobility, National Electric Vehicle Sweden, NEVS, NEVS 9-3 EV, product design, Saab Automobile AB, Shanghai CENAT New Energy Co Ltd, technology licenses, Trollhättan
Trollhättan, Sweden, 26-Jan-2017 — /EuropaWire/ — The Chinese government has today approved NEVS’ application to start production of electric vehicles in its manufacturing plant in Tianjin. – I am very grateful for the approval we now have received for the electric … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
